Categories
Market News Top 10 News

Britannia’s Net Profit Rises 47% YoY to Rs 559Cr in Q4 – Top Indian Market Updates

Here are some of the major updates that could move the markets on Monday:

Britannia Q4 Results: Net profit jumps 47% YoY to Rs 559 crore

Britannia Industries reported a 47% YoY increase in consolidated net profit to Rs 559 crore for Q4 FY23. Its operating revenue rose 13% YoY to Rs 4,023 crore during the quarter. EBITDA stood at Rs 800 crore, up 45.7% YoY from Rs 550 crore in Q4FY22.

Read more here.

India’s forex reserves rise by $4.53 billion to $588.78 billion

India’s foreign exchange reserves increased by $4.53 billion to $588.78 billion as of April 28, 2023, according to the Reserve Bank of India (RBI). Foreign currency assets rose by $4.99 billion to $519.48 billion. However, the country’s gold reserves fell by $4.94 million to $45.65 billion.

Read more here.

Federal Bank Q4 Results: Net profit jumps 67% YoY to Rs 903 crore

Federal Bank reported a 67% YoY jump in net profit to Rs 903 crore for Q4 FY23. Its consolidated total revenue rose 38.6% YoY to Rs 5,780 crore during the quarter. The bank’s Net Interest Income (NII) for the quarter stood at Rs 1,909 crore, up 25.2% YoY. The bank’s board has recommended a dividend of Rs 1 per equity share.

Read more here.

Marico Q4 Results: Net profit jumps 19% YoY to Rs 305 crore

Marico reported a 19% YoY increase in consolidated net profit to Rs 305 crore for Q4 FY23. Its operating revenue increased 3.65% YoY to Rs 2,240 crore during the quarter. EBITDA stood at Rs 393 crore in Q4 FY23, up 14% YoY. However, its net profit fell by 8.41% compared to Q3FY23.

Read more here.

Dr Reddy’s Labs launches Regadenoson injection in the US market

Dr. Reddy’s Laboratories has launched Regadenoson injection, a generic therapeutic equivalent of Lexiscan injection, in the US market. The injection is used in imaging heart muscle to check blood flow. However, the company has also received one observation from the US FDA after a routine GMP inspection at its API manufacturing facility in Bollaram, Hyderabad.

Read more here.

ITC increases stake in Bengaluru-based Sproutlife Foods

ITC has increased its shareholding in Sproutlife Foods to 39.42% after acquiring 2,443 equity shares and 7,215 Compulsorily Convertible Preference shares. The transaction was worth Rs 175 crore. ITC had previously announced plans to acquire a 100% stake in Sproutlife in tranches over the next three to four years. Sproutlife is a Bengaluru-based start-up in the innovative food products sector.

Read more here.

Lupin acquires entire stake in French pharma company Medisol

Lupin Ltd has acquired French pharmaceutical company Medisol for €18 million, subject to approval from the French Ministry of Economy and Finance. The acquisition will give Lupin access to Medisol’s portfolio of seven injectable products across four therapeutic areas, including pain management, anti-inflammatory, cardiovascular diseases, and obstetrics.

Read more here.

Bharat Forge Q4 Results: Net profit falls 7% YoY to Rs 245 crore

Bharat Forge reported a 7% YoY fall in net profit to Rs 245 crore for Q4 FY23. Its operating revenue increased 19.3% YoY to Rs 1,997 crore from Rs 1,674 crore during the same period. EBITDA stood at Rs 488 crore in Q4 FY23, up 13.2% YoY. The company’s board has recommended a dividend of Rs 5.5 per equity share.

Read more here.

MSCI assigns lower weight for the merged entity of HDFC Bank and HDFC 

MSCI will add HDFC Bank to the large-cap segment of its Global Standard Indices following its merger with HDFC. The move is expected to lead to no significant inflows, but there may be slight outflows of up to $200 million, according to Nuvama Alternative & Quantitative Research. As a result, MSCI will delete HDFC from its Global Standard Indexes at the end of the stock’s last trading day.

Read more here.

Blue Star declares 1:1 bonus issue of shares 

Blue Star has announced a 1:1 bonus issue of shares. This means that every shareholder of the company will be given an additional share. The move is subject to approval by shareholders, with the record date to be decided by the Board following this. The bonus issue aims to increase retail participation in the stock and the equity base.

Read more here.

Categories
Market News Top 10 News

Vedanta Reports 95% QoQ Rise in Net Profit in Q4 – Top Indian Market News

Vedanta Q4 Results: Net profit rises 95% QoQ to Rs 6,432 crore

Vedanta Limited reported a 95% quarter-on-quarter (QoQ) increase in net profit to Rs 6,432 crore for the quarter ended March (Q4). Its net sales rose 24% QoQ to Rs 28,206 crore during the same period. This revenue growth was aided by a rise in volumes of its aluminium, zinc, and iron ore businesses. Operating margins fell to 32%, compared with 34% in the preceding quarter (Q3 FY21). Earnings before interest, tax, depreciation, and amortisation (EBITDA) increased by 17% to Rs 9,037 crore.

Read more here.

Piramal Enterprises Q4 Results: Net loss at Rs 510 crore

Piramal Enterprise Ltd reported a consolidated net loss of Rs 510 crore for the quarter ended March (Q4 FY21). It had posted a net loss of Rs 1,702 crore in the corresponding period last year. The company’s revenue rose to Rs 3,402 crore in Q4 FY21, compared with Rs 3,341 crore in Q4 FY20. In the last two years, the company’s net debt has reduced by 45% to Rs 24,968 crore. The board of Piramal Enterprises has recommended a dividend of Rs 33 per share.

Read more here.

HCC-KEC JV secures order worth Rs 1,147 crore from Chennai Metro Rail

Hindustan Construction Company (HCC), in a joint venture (JV) with KEC International Ltd, has secured a contract worth Rs 1,147 crore from Chennai Metro Rail. The order includes the construction of a 7.96 km elevated viaduct and 9 elevated stations on Corridor 4 of Phase-II of the Chennai Metro. The scope of work involves civil, architectural, plumbing & drainage, and temporary services. HCC holds a 51% stake in the JV, while KEC International holds 49% stake.

Read more here.

Lupin Q4 Results: Net profit rises 18% YoY to Rs 460 crore

Lupin Limited reported an 18% YoY increase in consolidated net profit to Rs 460 crore for the quarter ended March (Q4 FY21). On a quarterly basis, net profit has risen by 5%. Its revenue from operations declined by 1.6% YoY to Rs 3,783 crore during the same period. For the financial year ended March 31, 2021 (FY21), net profit stood at Rs 1,216 crore. The company had posted a net loss of Rs 269 crore in the previous financial year (FY20). Lupin’s board has recommended a dividend of Rs 6.5 per share. 

Read more here.

Happiest Minds Q4 Results: Net profit falls 14% QoQ to Rs 36 crore

Happiest Minds reported a 14.5% quarter-on-quarter (QoQ) decline in net profit Rs 36.05 crore for the quarter ended March (Q4 FY21). Net profit has jumped 580% when compared to the corresponding period last year. The IT firm’s revenue declined 14.5% QoQ (up 18.4% YoY) to Rs 220.7 crore during the same period. In US Dollar terms, revenues for the March quarter grew 15.4% QoQ and 18% YoY to $30.2 million. The company added 23 clients during Q4, taking the total number of clients to 173 as of March 31, 2021. The board of Happiest Minds has recommended a final dividend of Rs 3 per share.

Read more here.

Reliance Jio tops in 4G download speed, Vodafone in upload speed in April: TRAI

According to data released by the Telecom Regulatory Authority of India (TRAI), Reliance Jio has topped the 4G speed chart in April 2021 with a data download rate of 20.1 megabits per second (Mbps). Vodafone was ahead of others in upload speed at 6.7 Mbps. Jio has almost three times higher download speed compared to Vodafone. The average speed is computed by TRAI based on the data it collects across India with the help of its MySpeed application on a real-time basis.

Read more here.

Pidilite Industries Q4 Results: Net profit rises 96% YoY to Rs 307 crore

Pidilite Industries reported a 96.4% YoY increase in consolidated net profit to Rs 307.44 crore for the quarter ended March (Q4). Its sales revenue rose 44.7% YoY to Rs 2,235.52 crore during the same period. Pidilite’s Consumer and Bazaar (C&B) segment posted a 45% YoY volume growth during the quarter. For the financial year ended March 31, 2021 (FY21), net profit rose 0.4% YoY to Rs 1,126.13 crore. The company’s board has announced a dividend of Rs 8.5 per share.

Read more here.

SBI Cards, Apollo Hospital, 3 Adani Group stocks enter MSCI India index

According to a release by index provider MSCI, Adani Enterprises, Adani Total Gas, and Adani Transmission have entered the MSCI India Domestic Index. SBI Cards and Payment Services and Apollo Hospital have also entered the leading index, which is being tracked widely by global investors. Zee Entertainment Enterprises has been deleted from the MSCI India index. All changes will be implemented as of May 27, 2021. According to Edelweiss Securities, India is expected to see a net inflow of $350 million from Foreign Institutional Investors (FIIs) following the adjustments made by MSCI in its global standard indices.

Read more here.

IEX Q4 Results: Net profit rises 33% YoY to Rs 60.85 crore

Indian Energy Exchange (IEX) reported a 33% YoY increase in consolidated net profit to Rs 60.85 crore for the quarter ended March (Q4). Its total income rose to Rs 100.33 crore, compared with Rs 79.59 crore in the corresponding period last year (Q4 FY20). For the financial year ended March 31, 2021 (FY21), net profit stood at Rs 205.43 crore. This is compared with a net profit of Rs 175.71 crore in FY20.

Read more here.

Vinati Organics Q4 Results: Net profit declines 5% YoY to Rs 70.85 crore

Vinati Organics Limited reported a 5.06% YoY decline in net profit to Rs 70.85 crore for the quarter ended March (Q4). Its revenue from operations rose 14.03% YoY to Rs 279.77 crore during the same period. For the financial year ended March 31, 2021 (FY21), net profit declined by 19.32% YoY to Rs 269.32 crore. The company’s board has approved a final dividend of Rs 6 per share. Vinati Organics is a leading specialty chemicals company based in Mumbai.

Read more here.

Eli Lilly signs licensing agreements with Torrent Pharma, Dr Reddy’s for Covid-19 drug

US-based drug firm Eli Lilly and Company has signed voluntary licensing agreements with Torrent Pharma, Dr Reddy’s Laboratories, and MSN Laboratories to expand the availability of Covid-19 drug Baricitinib in India. The drug is used in combination with Remdesivir for the treatment of Covid-19 patients with severe symptoms. On Monday, Eli Lilly had issued voluntary licenses to Cipla, Lupin, and Sun Pharma to manufacture and sell Baricitinib. This will enable the Indian pharma companies to use their existing distribution systems to ensure that the essential drug is accessible across the country.

Read more here.

Categories
Editorial

Why are FIIs Pushing NIFTY Up?

Firstly, it is important to be aware of who actually FIIs are. FII stands for Foreign Institutional Investors. You can imagine them as a fundhouse or an institution which is registered outside India but is interested in investing in Indian market. They also have to be registered with SEBI, who is the Securities watchdog of India. These FIIs are also known as FPIs or Foreign Portfolio Investors.

Foreign Institutional Investors are pumping a lot of money in India. According to the data, they pumped a whopping Rs 62,951 crore in Indian markets in November 2020. This is the highest amount of money ever invested by the FPI within a month. Out of the total Rs 62,951 crore, Rs 60,358 crore went into equities and Rs 2,593 crore went in the debt segment. In fact, in November, the FIIs turned to be a net seller for just one day. That day too, they were a net seller for only Rs 78.53 crore. In October as well, FIIs were the net buyers as they invested Rs 22,033 crore. Just like you, even we were curious why is suddenly India being chosen as a preferred location to invest? Let’s find out here.

Prime Minister’s meet with the FIIs

It is for the first time FII buying in equities has crossed Rs 50,000 crore in a month. We believe Prime Minister Narendra Modi’s meeting with the FIIs played a major role behind the investment. Early in November, the PM met the world’s 20 largest pension and sovereign wealth funds at a virtual roundtable. The meeting was called the Virtual Global Investor Roundtable (VGIR) conference 2020. In this meeting, PM Modi highlighted India’s potential and its huge untapped market. He assured that his government is committed to making India economically robust. He invited them to be a part of India’s growth story and benefit from it. 

“India’s quest to become AatmaNirbhar is not just a vision but a well-planned economic strategy; a strategy that aims to use the capabilities of our businesses and skills of our workers to make India into a global manufacturing powerhouse. If you want returns with reliability, India is the place to.”– PM Narendra Modi.

This positive commentary coming from a strong leader such as Narendra Modi did have a huge effect. He was successful to lure them to put the massive quantum of money in India. The Prime Minister was vocal that they are looking to back domestic companies to thrive against foreign competition. Also, campaigns such as “Vocal for Local” and “Atmanirbhar Bharat” will suggest people to buy domestic products rather than go for a bit cheaper foreign products. 

The virtual global investor roundtable was attended by the investors from countries like Canada, Korea, US, Europe, Middle East and Australia. Some of the investors which were present are Mubadala Investment Company, Ontario Teachers, Singapore-based GIC Pvt. Ltd, Future Fund, Japan Post Bank and Temasek Holdings. Apart from foreign investors, big Indian industrialists like Mukesh Ambani (Reliance Industries), Nadan Nilekani (Infosys), Ratan Tata (Tata Group) and few others were a part of the VGIR 2020 conference.

A Boost from MSCI 

Morgan Stanley Capitals International (MSCI) is one of the biggest and reputed investment banks and financial services companies in the world. They provide stock indexes, portfolio risk and performance analytics. This index consists of stocks which can outperform and give better returns. MSCI decided to restructure its emerging market index which increased India’s weightage from 8.1% to 8.7%. What does that mean? This means that there will be an indirect inflow of about $2.5 billion (Rs 18,500 crore) to the Indian securities. These are the securities which are a part of MSCI’s Emerging Market Index. The stocks which were added to the list were:

  • Kotak Mahindra Bank
  • Adani Green
  • Apollo Hospitals
  • Yes Bank
  • Balkrishna Industries
  • Trent
  • L&T Infotech
  • MRF
  • IPCA Labs
  • ACC
  • PI Industries
  • Muthoot Finance

When the list was made public, all of these stocks saw a surge in their share prices. Retail investors followed FPIs footpath and started buying more of these stocks, thus, taking the prices higher.

The Great Indian economy

We all know that India introduced one of the most strict lockdowns in the world in March. It led to a horrific yet anticipated 23.9% contraction in Q1 FY21. Since then, the lockdown norms have been eased up by the central government and businesses are allowed to operate. In Q2FY21 (July-September), India’s real GDP contracted by 7.5%. This meant that India entered into a technical recession for the first time in 41 years. Ominous signs, right? Not exactly. What we understand is that people were expecting a contraction of around 10% in the second quarter. A stronger performance has turned the investors, especially the FIIs, bullish on the Indian market

They believe when it comes to investing in an emerging country, India might be one of the best options available. Rating agency Moody’s Investors Service has revised its position on the Indian economy. Earlier, they forecasted a slump of 9.6% for this calendar year. As the economy is trying to recover, they have revised their forecast to a contraction of 8.9%. The Reserve Bank of India (RBI) has recently predicted that the Indian economy will stop shrinking from this quarter. They foresee a GDP growth of 0.1% for the quarter ending December. They also expect the economy to contract by 7.5% in FY21 rather than 9.5% which they anticipated earlier. A strong rebound in the economy is what people are expecting. Whether it would be a K-shaped, V-shaped or U-shaped recovery is a different topic to discuss.

The Way Ahead

The rally which seemed to hit its peak in November has carried on in December as well. On all the first 13 days of this new month, FIIs have been a net buyer each day. They have invested more than Rs 25,000 crore till 13 December alone. With this pace, November’s record could be broken easily. Coronavirus cases in India kept decreasing in November. This positive news, along with the opening up of the economy gave confidence to the investors. Also, one point to note that India is a very young country demographically. Statistically, we have seen coronavirus to be more deadly for older people. There might be a case where the foreign investors are banking on the younger population to come out better in this pandemic. With all these reasons in place, we believe that investors might keep flowing in the money as they hope to profit from India’s recovery in the pandemic. 

Categories
Editorial

Morgan Stanley Index to Push Markets Up – MSCI Rejig

The last week of October began with a rocky start. On Monday, we saw that Nifty 50 was down by 162.60 points (or 1.36%), and closed at 11,767.75. The fall in Reliance Industries (RIL), decline in the auto sector, and the imposition of lockdown in Spain were three major reasons that caused a sharp fall in Nifty. Click here for our detailed post-market report for Monday. To make matters worse, the European and US market was down by 3% and 2%, respectively. Investors were asked to be very cautious while entering into a trade on Tuesday. 

However, in a surprising turn of events, Nifty went up by 1.03% on Tuesday. Against all odds, Nifty saw a rise of 121.65 points, and closed at 11,889. Let us have a detailed understanding of one major reason as to why there was a great recovery in our Indian market.

The MSCI Index

On Tuesday, most of us did not get a chance to go through a major report that was published in the afternoon. However, the stocks mentioned in this report were the ones that showed a great performance in our markets. The report had details about Morgan Stanley’s Emerging Market Index. 

Morgan Stanley Capitals International (MSCI Inc.) is one of the largest investment banks and financial services companies in the world. The US-based firm is a major index provider and publishes three major indexes. An index usually measures or tracks the performance of a group of assets or securities.

Coming back to the point, the report mentioned that Morgan Stanley is going to restructure or reorganize its Emerging Market Index. What this meant was that India’s weightage in this highly important index would be increased to 8.7%, from the current level of 8.1%. Ultimately, this would result in an additional indirect inflow of about $2.5 billion (~Rs 18,430 crore) to the Indian securities that are included in the index. According to Morgan Stanley, the major companies such as Asian Paints, Bajaj Finance, Britannia, L&T, and Nestle India would highly benefit from this change. These companies could see an increase in investment by approximately $200 million (~Rs 1,474 crores).

How Does this Process Work?

In order to understand this process more clearly, we shall look at an example. In India, we have the Nifty 50 index which includes Nestle India Limited. At a point in time, a major financial company or analyst might say that the weightage of Nestle is going to be increased in the Nifty index. Mutual funds and Exchange Traded Funds (ETFs) who are tracking this index will start pouring more funds into the stock. This confidence from big players will also make small retailers invest more money into the company. Eventually, the share prices of Nestle would have a high chance of increasing. This is exactly one of the major reasons as to why there was a rise in Nifty on Tuesday.

Top Gainers on Tuesday

  1. Kotak Bank – 11.70%  
  2. Nestle India – 5.97%
  3. Asian Paints – 5.69%
  4. Bajaj Finance – 4.38%

Almost all the top gainers are companies that were listed on the report of Morgan Stanley. Certain financial analysts have also stated that companies such as Apollo Hospitals, LIC Housing Finance, Ipca Laboratories, and Kotak Bank may also be included in the MSCI indices

Do bear in mind that the original results of the MSCI Emerging Market Index would be announced on November 11. It would also include the list of stocks that would be added, along with the changes in its weightage. These changes would finally be effective from 1st December 2020. So the point is that even the funds have not actually flowed into these stocks, the positive sentiment around them is what pushed them up.

An important takeaway from this would be to carefully go through relevant market news. Very specific and highly important news (such as this report from a giant like Morgan Stanley) would have a huge impact on how markets perform on a specific day. It is also encouraging to understand how our Indian companies are performing, and would help us achieve handsome profits in the long term and win in the stock market.

Update on November 11:

The revisions to the MSCI Emerging Markets Index was announced on November 11. The following table shows the list of stocks that are added, and the stocks that have been excluded from the standard index.

Stocks that are AddedStocks that are Excluded
1. Kotak Mahindra Bank1. LIC Housing
2. Adani Green2. Bosch
3. Yes Bank
4. Apollo Hospitals
5. MRF
6. IPCA Labs
7. Balkrishna Industries
8. L&T Infotech
9. Trent
10. PI Industries
11. Muthoot Finance
12. ACC